BCBS Michigan changed the prior authorization criteria for Zepbound (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide) from August 1, 2024, through December 31, 2024
Combined-pathway designs Explored in study designs comparing single peptides against a multi-component blend
These effects can improve glucose tolerance, which is especially meaningful in Type 2 Diabetes and Metabolic Syndrome
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders, Nature Medicine
In particular, increased concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-8 (IL-8), as well as alterations in the anti-inflammatory cytokine interleukin-10 (IL-10) and specific chemokines, have been described [27]
The 2-month washout is about teratogenic risk, not about restoring reproductive function